marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Brainstorm Cell Therapeutics Balance Sheet 2011-2024 | BCLI
Annual Balance Sheet Brainstorm Cell Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-25 K | 3.32 M | -13.8 M | -30.6 M | 1.83 M | -942 K | -2.48 M | -547 K | -428 K | -4.25 M | -3.5 M | -1.32 M | -1.92 M |
Long Term Debt |
672 K | 2.67 M | 3.62 M | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
603 K | 1.43 M | 1.46 M | 2.66 M | 1.26 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
1.27 M | 2.67 M | 3.62 M | 4.56 M | 1.1 M | - | - | - | - | 123 K | 655 K | 189 K | 121 K |
Total Current Liabilities |
7.8 M | 8.8 M | 6.32 M | 11.2 M | 17.7 M | 6.21 M | 5.54 M | 864 K | 2.95 M | 3.11 M | 1.33 M | 1.14 M | 1.14 M |
Total Liabilities |
9.07 M | 11.5 M | 9.94 M | 15.8 M | 18.8 M | 6.21 M | 5.54 M | 864 K | 2.95 M | 3.24 M | 1.99 M | 1.33 M | 1.26 M |
Deferred Revenue |
- | - | - | - | - | - | 2.62 M | - | - | - | - | - | - |
Retained Earnings |
-215 M | -198 M | -174 M | -149 M | -117 M | -94 M | -80.1 M | -75.1 M | -70.1 M | -61.7 M | -52.4 M | -47.5 M | -44.1 M |
Total Assets |
4.21 M | 8.45 M | 29.3 M | 51.3 M | 6.53 M | 11.2 M | 11.4 M | 10.8 M | 17.1 M | 9.91 M | 4.73 M | 5.31 M | 2.74 M |
Cash and Cash Equivalents |
1.3 M | 772 K | 18.9 M | 37.8 M | 536 K | 942 K | 2.48 M | 547 K | 428 K | 4.25 M | 3.5 M | 1.32 M | 1.92 M |
Book Value |
-4.86 M | -3.02 M | 19.3 M | 35.5 M | -12.2 M | 5.02 M | 5.88 M | 9.9 M | 14.1 M | 6.68 M | 2.74 M | 3.98 M | 1.49 M |
Total Shareholders Equity |
-4.86 M | -3.02 M | 19.3 M | 35.5 M | -12.2 M | 5.02 M | 5.88 M | 9.9 M | 14.1 M | 6.68 M | 2.74 M | 3.98 M | 1.49 M |
All numbers in USD currency
Quarterly Balance Sheet Brainstorm Cell Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
271 K | 396 K | 533 K | 672 K | 1.58 M | 1.94 M | 2.29 M | 2.67 M | 2.92 M | 3.26 M | 3.93 M | 3.62 M | 3.77 M | 4 M | 4.18 M | 4.56 M | 4.56 M | 4.56 M | 4.56 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
1 M | 1.52 M | 2.07 M | 1.27 M | 1.94 M | 1.94 M | 2.29 M | 2.67 M | 2.92 M | 3.26 M | 3.93 M | 3.62 M | 3.77 M | 4 M | 4.18 M | 4.56 M | 4.56 M | 4.56 M | 4.56 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 123 K | 123 K | 123 K | 123 K | 655 K | 655 K | 655 K | 655 K | - | - | - | - | - | - | - | - |
Total Liabilities |
8.08 M | 9.21 M | 8.9 M | 9.07 M | 8.26 M | 9.63 M | 12.7 M | 11.5 M | 11.9 M | 11.1 M | 11.3 M | 9.94 M | 9.61 M | 12.1 M | 12.4 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 6.21 M | 6.21 M | 6.21 M | 6.21 M | 5.54 M | 5.54 M | 5.54 M | 5.54 M | 864 K | - | - | - | 2.95 M | 2.84 M | 2.53 M | 2.73 M | 3.24 M | 3.24 M | 3.24 M | 3.24 M | 1.99 M | 1.99 M | 1.99 M | 1.99 M | 1.16 M | 1.33 M | 1.33 M | 1.33 M | 1.26 M | 1.26 M | 1.26 M | 1.26 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-224 M | -221 M | -218 M | -215 M | -209 M | -208 M | -203 M | -198 M | -193 M | -186 M | -179 M | -174 M | -167 M | -162 M | -156 M | -149 M | -149 M | -149 M | -149 M | -117 M | -117 M | -117 M | -117 M | -94 M | -94 M | -94 M | -94 M | -80.1 M | -80.1 M | -80.1 M | -80.1 M | -75.1 M | -75.1 M | -75.1 M | -75.1 M | -70.1 M | -70.1 M | -70.1 M | -70.1 M | -61.7 M | -61.7 M | -61.7 M | -61.7 M | -52.4 M | -52.4 M | - | - | - | - | - | - | - | - | - | - |
Total Assets |
2.02 M | 5.68 M | 3.35 M | 4.21 M | 5.68 M | 5.75 M | 7.87 M | 8.45 M | 13.3 M | 19 M | 25.8 M | 29.3 M | 34.5 M | 42.2 M | 48.6 M | 51.3 M | 51.3 M | 51.3 M | 51.3 M | 6.53 M | 6.53 M | 6.53 M | 6.53 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 10.8 M | 10.8 M | 10.8 M | 10.8 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 9.91 M | 9.91 M | 9.91 M | 9.91 M | 4.73 M | 4.73 M | 4.73 M | 4.73 M | 5.14 M | 5.31 M | 5.31 M | 5.31 M | 2.74 M | 2.74 M | 2.74 M | 2.74 M |
Cash and Cash Equivalents |
168 K | 3.47 M | 779 K | 1.3 M | 1.22 M | 546 K | 2.02 M | 772 K | 4.14 M | 9 M | 15.2 M | 18.9 M | 25.7 M | 30.6 M | 35.9 M | 37.8 M | 37.8 M | 37.8 M | 37.8 M | 536 K | 536 K | 536 K | 536 K | 942 K | 942 K | 942 K | 942 K | 2.48 M | 2.48 M | 2.48 M | 2.48 M | 547 K | 547 K | 547 K | 547 K | 428 K | 428 K | 428 K | 428 K | 4.25 M | 4.25 M | 4.25 M | 4.25 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 1.32 M | 1.32 M | 1.32 M | 1.32 M | 1.92 M | 1.92 M | 1.92 M | 1.92 M |
Book Value |
-6.06 M | -3.53 M | -5.55 M | -4.86 M | -2.58 M | -3.88 M | -4.84 M | -3.02 M | 1.39 M | 7.85 M | 14.5 M | 19.3 M | 24.9 M | 30.2 M | 36.2 M | 35.5 M | 35.5 M | 35.5 M | 35.5 M | -12.2 M | -12.2 M | -12.2 M | -12.2 M | 5.02 M | 5.02 M | 5.02 M | 5.02 M | 5.88 M | 5.88 M | 5.88 M | 5.88 M | 9.9 M | 10.8 M | 10.8 M | 10.8 M | 14.1 M | 14.2 M | 14.6 M | 14.4 M | 6.68 M | 6.68 M | 6.68 M | 6.68 M | 2.74 M | 2.74 M | 2.74 M | 2.74 M | 3.98 M | 3.98 M | 3.98 M | 3.98 M | 1.49 M | 1.49 M | 1.49 M | 1.49 M |
Total Shareholders Equity |
-6.06 M | -3.53 M | -5.55 M | -4.86 M | -2.58 M | -3.88 M | -4.84 M | -3.02 M | 1.39 M | 7.85 M | 14.5 M | 19.3 M | 24.9 M | 30.2 M | 36.2 M | 35.5 M | 35.5 M | 35.5 M | 35.5 M | -12.2 M | -12.2 M | -12.2 M | -12.2 M | 5.02 M | 5.02 M | 5.02 M | 5.02 M | 5.88 M | 5.88 M | 5.88 M | 5.88 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 14.1 M | 14.1 M | 14.1 M | 14.1 M | 6.68 M | 6.68 M | 6.68 M | 6.68 M | 2.74 M | 2.74 M | 2.74 M | 2.74 M | 3.98 M | 3.98 M | 3.98 M | 3.98 M | 1.49 M | 1.49 M | 1.49 M | 1.49 M |
All numbers in USD currency